| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bellevue Life Sciences Acquisition Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.95 |
| 52 Week High | US$12.00 |
| 52 Week Low | US$10.09 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 2.53% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 7.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| BLAC.U | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | 0.9% |
| 1Y | 2.5% | 41.7% | 32.3% |
Return vs Industry: BLAC.U underperformed the US Capital Markets industry which returned 41.7% over the past year.
Return vs Market: BLAC.U underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| BLAC.U volatility | |
|---|---|
| BLAC.U Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: BLAC.U has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BLAC.U's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Peter Hwang | www.bellevuespac.com |
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.
Bellevue Life Sciences Acquisition Corp. Fundamentals Summary
| BLAC.U fundamental statistics | |
|---|---|
| Market cap | US$44.01m |
| Earnings (TTM) | -US$165.71k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-265.6x
P/E RatioIs BLAC.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLAC.U income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$165.71k |
| Earnings | -US$165.71k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.041 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -32.5% |
How did BLAC.U perform over the long term?
See historical performance and comparison